RS49672B - Difenilalkil-tetrahidropiridini, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže - Google Patents

Difenilalkil-tetrahidropiridini, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže

Info

Publication number
RS49672B
RS49672B YUP-263/99A YU26399A RS49672B RS 49672 B RS49672 B RS 49672B YU 26399 A YU26399 A YU 26399A RS 49672 B RS49672 B RS 49672B
Authority
RS
Serbia
Prior art keywords
group
butyl
phenyl group
tetrahydropyridines
preparation
Prior art date
Application number
YUP-263/99A
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi-Aventis,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis, filed Critical Sanofi-Aventis,
Publication of YU26399A publication Critical patent/YU26399A/sh
Publication of RS49672B publication Critical patent/RS49672B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Jedinujenje formule (I): gde je Y, -CH- ili –N-; R1 je halogen, CF3, (C1-C4)alkil ili (C1-C4)alkoksil grupu; R2 i R3 svaki vodonik ili (C1-C3)alkil; n je 0 ili 1; Ph1 i Ph2 svaki, nezavisno, fenil grupa; fenil grupa koja je položaju 2-, 3- ili 4-, supstituisanu jednim atomom fluora ili hlora, ili metil, etil, n-propil, i-propil, n-butil, i-butil, s-butil, t-butil, trifluormetil, cijano, metoksi, metiltio, metilsulfonil, etoksi, etiltio, etilsulfonil, (C1-C3)alkoksikarbonil ili di(C1-C3)alkilaminokarbonil grupom; fenil grupa koja je u položajima 2,4-; 3,4-; 3,5- ili 2,6- disupstituisana atomom hlora ili fluora, ili metil, etil, trifluorometil, cijano ili metoksi grupom; ili fenil grupa koja je u položajima 3,4,5-; 2,4,5- ili 2,4,6- trisupstituisana atomom hlora ili fluora ili metil, etil, trifluormetil, cijano ili metoksi grupom. i njegove soli i solvati i njegove kvaternerne amonijumove soli. Prijava sadrži još 8 patentnih zahteva.
YUP-263/99A 1996-12-13 1997-12-12 Difenilalkil-tetrahidropiridini, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže RS49672B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines

Publications (2)

Publication Number Publication Date
YU26399A YU26399A (sh) 2000-03-21
RS49672B true RS49672B (sr) 2007-11-15

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-263/99A RS49672B (sr) 1996-12-13 1997-12-12 Difenilalkil-tetrahidropiridini, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže

Country Status (31)

Country Link
US (1) US6124318A (sr)
EP (1) EP0950049B1 (sr)
JP (1) JP2001505903A (sr)
KR (1) KR100549656B1 (sr)
CN (1) CN1144784C (sr)
AT (1) ATE207056T1 (sr)
AU (1) AU730142B2 (sr)
BR (1) BR9713926A (sr)
CA (1) CA2274946C (sr)
CY (1) CY2282B1 (sr)
CZ (1) CZ290242B6 (sr)
DE (1) DE69707504T2 (sr)
DK (1) DK0950049T3 (sr)
EE (1) EE03764B1 (sr)
ES (1) ES2167805T3 (sr)
FR (1) FR2757161B1 (sr)
HK (1) HK1024001A1 (sr)
HU (1) HUP0001437A3 (sr)
IL (2) IL130001A0 (sr)
IS (1) IS2001B (sr)
NO (1) NO313282B1 (sr)
NZ (1) NZ336032A (sr)
PL (1) PL192926B1 (sr)
PT (1) PT950049E (sr)
RS (1) RS49672B (sr)
RU (1) RU2198874C2 (sr)
SI (1) SI0950049T1 (sr)
SK (1) SK283332B6 (sr)
TR (1) TR199901290T2 (sr)
UA (1) UA52708C2 (sr)
WO (1) WO1998025904A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20030060487A1 (en) * 2000-04-12 2003-03-27 Bamdad R. Shoshana Treatment of neurodegenerative disease
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
US20050191349A1 (en) * 2003-12-31 2005-09-01 Garth Boehm Galantamine formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
AU730142B2 (en) 2001-03-01
ES2167805T3 (es) 2002-05-16
EP0950049A1 (fr) 1999-10-20
US6124318A (en) 2000-09-26
IL130001A0 (en) 2000-02-29
EE9900238A (et) 1999-12-15
RU2198874C2 (ru) 2003-02-20
WO1998025904A1 (fr) 1998-06-18
YU26399A (sh) 2000-03-21
FR2757161A1 (fr) 1998-06-19
DE69707504T2 (de) 2002-06-27
CA2274946C (en) 2005-09-20
NO992870D0 (no) 1999-06-11
NZ336032A (en) 2000-12-22
KR20000069421A (ko) 2000-11-25
NO992870L (no) 1999-08-11
IL130001A (en) 2006-04-10
HK1024001A1 (en) 2000-09-29
BR9713926A (pt) 2000-03-21
ATE207056T1 (de) 2001-11-15
CY2282B1 (en) 2003-07-04
JP2001505903A (ja) 2001-05-08
FR2757161B1 (fr) 1999-03-12
UA52708C2 (uk) 2003-01-15
EP0950049B1 (fr) 2001-10-17
DE69707504D1 (de) 2001-11-22
SK283332B6 (sk) 2003-06-03
PL192926B1 (pl) 2006-12-29
SK78799A3 (en) 1999-12-10
CN1144784C (zh) 2004-04-07
AU5489598A (en) 1998-07-03
CN1240428A (zh) 2000-01-05
SI0950049T1 (en) 2002-10-31
IS5074A (is) 1999-06-10
HUP0001437A2 (hu) 2000-09-28
IS2001B (is) 2005-04-15
TR199901290T2 (xx) 1999-08-23
KR100549656B1 (ko) 2006-02-08
CZ290242B6 (cs) 2002-06-12
CA2274946A1 (en) 1998-06-18
DK0950049T3 (da) 2002-01-28
HUP0001437A3 (en) 2001-12-28
NO313282B1 (no) 2002-09-09
CZ211099A3 (cs) 1999-09-15
EE03764B1 (et) 2002-06-17
PT950049E (pt) 2002-03-28
PL334073A1 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
DK0876350T3 (da) Pyrazolderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
RS50540B (sr) Substituisani piridinil i pirimidinil derivati kao modulatori metabolizma i lečenje poremećaja proisteklih iz toga
DE60137426D1 (de) 1,2-dihydropyridinverbindungen, verfahren zu deren herstellung und deren verwendung
DK7280A (da) Fremgangsmaade til fremstilling af (piperidinylalkyl) quinazolin-derivater
EP0040639A4 (en) ISOXAZOLE DERIVATIVES.
PL141641B1 (en) Agent for fighting against and/or preventing paralyzing effects of microorganisms and method of obtaining new derivatives of n-/2-nitrophenylo/-4-aminopyrimidiines
EP0077938A3 (en) N-(3-substituted aminophenyl) tetrahydrophthalimides and herbicidal composition
DK220386A (da) 2-(4-benzoyl-1-piperidinyl)-alkanolderivater, fremgangsmaade til fremstilling af saadanne derivater og anvendelse af disse som laegemidler
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
RS51351B (sr) 1,4-dihidropiridin-kondenzovani hterocikli, postupci za njihovo dobijanje, upotreba i kompozicije koje ih sadrže
IE811085L (en) Pyridoxine derivatives
YU44998A (sh) Pirazolska jedinjenja, postupci za njihovu proizvodnju i herbicidi koji ih sadrže
NO20065863L (no) 3-[4-(6-(4,5-dihydroisoksazol-3-yl]pyridin-3-yl)-3-fenyl]-5-(1 H,1,2,3-triazol-1-yl-metyl)-1,3-oksazolidin-2-oner som antibakterielle midler
HRP20090147T3 (en) Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
BG102959A (en) Benzooxazinon antagonists of domamine d4 receptor
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
RS49672B (sr) Difenilalkil-tetrahidropiridini, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
RS51126B (sr) Postupak za pripremanje mezilata piperazin derivata
ATE270289T1 (de) Heteroaryloxypropanolamine als beta3- adrenergischer rezeptor-agonisten
ES8502093A1 (es) Derivados de quinolina.
DK494482A (da) 2-imidazolylmethyl-2-phenyl-1,3-dioxolaner, fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
AU6615686A (en) Antihypertensive combination product
WO2002083644A1 (fr) Derives de quinoline halogenes et agents d'elimination des ectoparasites
ES8403456A1 (es) "procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica".
EA200400470A1 (ru) Замещенные производные алкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции